Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04165564 · ClinicalTrials.gov registry record

DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers

A clinical trial of Pulmonary Disease, sponsored by Boston University.

Active
Registry status
85
Enrollment target
19
Study locations

NCT04165564 is a study of Pulmonary Disease that is active but no longer recruiting, run by Boston University. The registered enrollment target is 85 participants, below the 620-participant average among 19 other Pulmonary Disease trials with a reported enrollment target (86% lower). The trial reports 19 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04165564, a study of Pulmonary Disease, is active but no longer recruiting, sponsored by Boston University.

ACTIVE NOT RECRUITING
Registry status
85 participants
Enrollment target
19
Study locations

Study Summary

DECAMP 1 PLUS aims to improve the efficiency of the diagnostic evaluation of patients with indeterminate pulmonary nodules (8-25 mm). Molecular biomarkers for lung cancer diagnosis measured in minimally invasive and non-invasive biospecimens may be able to distinguish between malignant or benign indeterminate pulmonary nodules in high-risk smokers. Ultimately, this study aims to validate molecular as well as clinical and imaging biomarkers of lung cancer in individuals with indeterminate lung nodules.

Conditions Studied

Pulmonary Disease

Interventions

  • OTHER Institutional standard of care
  • OTHER Biosamples of airway and blood

Study Locations (19)

Pennsylvania

  • American College of Radiology [Administrative Site] - Philadelphia
  • University of Pennsylvania School of Medicine - Philadelphia
  • Temple University - Philadelphia
  • University of Pittsburgh Medical Center - Pittsburgh

California

  • University of California Los Angeles - Los Angeles
  • VA Greater LA Healthcare System - Los Angeles
  • Naval Medical Center San Diego - San Diego

Alabama

  • University of Alabama, Birmingham - Birmingham

Iowa

  • University of Iowa - Iowa City

Maryland

  • Walter Reed Army Medical Center - Bethesda

Massachusetts

  • VA Boston Healthcare System - Boston

Michigan

  • University of Michigan - Ann Arbor

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2020-08-24
Est. Completion 2026-12

Sponsor

Boston University

185 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04165564

The ClinicalTrials.gov registry entry for NCT04165564 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 620-participant average among 19 other Pulmonary Disease trials with a reported enrollment target (86% lower). The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pulmonary Disease appearing as the primary indexed condition, and to 2 interventions - of which Institutional standard of care is the first listed.

NCT04165564 reports 19 study locations spanning 14 distinct geographic areas - top geographies include Pennsylvania, California, Alabama.

Frequently Asked Questions

What is clinical trial NCT04165564 about?

NCT04165564 is a clinical study titled "DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers". DECAMP 1 PLUS aims to improve the efficiency of the diagnostic evaluation of patients with indeterminate pulmonary nodules (8-25 mm). Molecular biomarkers for lung cancer diagnosis measured in minimally invasive and non-invasive biospecimens may be able to distinguish between malignant or benign ind...

What is the current status of trial NCT04165564?

This trial is currently active not recruiting. The enrollment target is 85 participants. The study started on 2020-08-24. Estimated completion is 2026-12.

What conditions does trial NCT04165564 study?

This clinical trial studies the following conditions: Pulmonary Disease.

What interventions are being tested in trial NCT04165564?

The interventions under investigation include: Institutional standard of care (OTHER), Biosamples of airway and blood (OTHER).

Who is sponsoring clinical trial NCT04165564?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04165564 being conducted?

This trial has 19 study locations across Alabama, California, Iowa, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pulmonary Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pulmonary Disease

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.